Tivanisiran (sodium)
Tivanisiran sodium is a siRNA used for the study of dry eye disease. Tivanisiran sodium was designed to silence transient receptor potential vanilloid 1 (TRPV1) mRNA[1].
Product Specifications
CAS Number
[1848239-71-3]
Product Name Alternative
SYL1001 (sodium)
UNSPSC
12352208
Target
TRP Channel
Type
Oligonucleotides
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tivanisiran-sodium.html
Purity
96.85
Solubility
10 mM in H2O
Smiles
[Tivanisiran(sodium)]
Molecular Formula
C361H411N141O262Na36P36
Molecular Weight
12068.3 (free acid)
References & Citations
[1]Anne-Marie Bleau, et al. Development of tivanisiran, a topical siRNA designed to|[2]Javier Moreno-Montañés, et al. Tivanisiran, a novel siRNA for the treatment of dry eye disease. Expert Opin Investig Drugs. 2018 Apr;27 (4) :421-426.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2136898-01 0.1 mL
APC_Cy7 Linked Monoclonal Antibody to Doublecortin Like Kinase 1 (DCLK1)
Ask
View Details MBS2136898-02 0.2 mL
APC_Cy7 Linked Monoclonal Antibody to Doublecortin Like Kinase 1 (DCLK1)
Ask
View Details MBS2136898-03 0.5 mL
APC_Cy7 Linked Monoclonal Antibody to Doublecortin Like Kinase 1 (DCLK1)
Ask
View Details MBS2136898-04 1 mL
APC_Cy7 Linked Monoclonal Antibody to Doublecortin Like Kinase 1 (DCLK1)
Ask
View Details